BIOMAT Database Logo BIOMAT Database Logo

Withdrawal of oxyphenbutazone: what about phenylbutazone? 1986

P Biron

UI MeSH Term Description Entries
D010113 Oxyphenbutazone A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27) Hydroxyphenylbutazone,Diflamil,Oxyphenylbutazone,Tanderil
D010653 Phenylbutazone A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS. Diphenylbutazone,Fenilbutazon,Butacote,Butadion,Butadione,Butapirazol,Butapyrazole,Butazolidin
D011634 Public Health Branch of medicine concerned with the prevention and control of disease and disability, and the promotion of physical and mental health of the population on the international, national, state, or municipal level. Community Health,Environment, Preventive Medicine & Public Health,Environment, Preventive Medicine and Public Health,Health, Community,Health, Public
D002170 Canada The largest country in North America, comprising 10 provinces and three territories. Its capital is Ottawa.
D004345 Drug Industry That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function. Industries, Pharmaceutic,Industry, Drug,Industry, Pharmaceutic,Industry, Pharmaceutical,Pharmaceutical Industry,Drug Industries,Industries, Drug,Industries, Pharmaceutical,Pharmaceutic Industries,Pharmaceutic Industry,Pharmaceutical Industries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Biron
Phenylbutazone and oxyphenbutazone.
April 1973, The Medical letter on drugs and therapeutics,
P Biron
Phenylbutazone, oxyphenbutazone labeling revised.
December 1984, FDA drug bulletin,
P Biron
Phenylbutazone, oxyphenbutazone and aplastic anaemia.
July 1977, British medical journal,
P Biron
Studies with phenylbutazone, oxyphenbutazone, and para-paradichloro phenylbutazone in horses.
October 1969, The Cornell veterinarian,
P Biron
Fixed drug eruption to oxyphenbutazone and phenylbutazone.
January 1972, Dermatologica,
P Biron
Inhibition of phenylbutazone elimination by its metabolite oxyphenbutazone.
December 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
P Biron
[Clinical and experimental studies on phenylbutazone and oxyphenbutazone].
August 1965, Arzneimittel-Forschung,
P Biron
Generalized pustular psoriasis precipitated by phenylbutazone and oxyphenbutazone.
July 1983, The British journal of dermatology,
P Biron
Phenylbutazone and oxyphenbutazone: time to call a halt.
January 1984, Drug and therapeutics bulletin,
P Biron
Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
November 1977, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!